4.7 Article

Conjugated bile acids attenuate allergen-induced airway inflammation and hyperresposiveness by inhibiting UPR transducers

Journal

JCI INSIGHT
Volume 4, Issue 9, Pages -

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/jci.insight.98101

Keywords

-

Funding

  1. NIH [R01 HL122383, HL141364, HL 136917]
  2. Department of Pathology and Laboratory Medicine
  3. Parker B. Francis Fellowship
  4. ATS-Joe Rae Wright award
  5. T32 training grant graduate student fellowship [T32HL076122]
  6. Department of Pathology and Laboratory Medicine graduate student fellowship
  7. Pennsylvania Department of Health, Tobacco Commonwealth Universal Research Enhancement Program Funds
  8. CJ Martin Fellowship from the National Medical Research Council of Australia [NHMRC-ECF 1053790]

Ask authors/readers for more resources

Conjugated bile acids (CBAs), such as tauroursodeoxycholic acid (TUDCA). are known to resolve the inflammatory and unfolded protein response (UPR) in inflammatory diseases, such as asthma. Whether CBAs exert their beneficial effects on allergic airway responses via 1 arm or several arms of the UPR, or alternatively through the signaling pathways for conserved bile acid receptor. remains largely unknown. We used a house dust mite-induced (HDM-induced) murine model of asthma to evaluate and compare the effects of 5 CBAs and 1 unconjugated bile acid in attenuating allergen-induced UPR and airway responses. Expression of UPR-associated transcripts was assessed in airway brushings from human patients with asthma and healthy subjects. Here we show that CBAs, such as alanyl beta-muricholic acid (A beta W) and TUDCA, significantly decreased inflammatory, immune, and cytokine responses; mucus metaplasia; and airway hyperresponsiveness, as compared with other CBAs in a model of allergic airway disease. CBAs predominantly bind to activating transcription factor 6 alpha (ATF6 alpha) compared with the other canonical transducers of the UPR, subsequently decreasing allergen-induced UPR activation and resolving allergic airway disease, without significant activation of the bile acid receptors. TUDCA and A beta M also attenuated other MOM-induced ER stress markers in the lungs of allergic mice. Quantitative mRNA analysis of airway epithelial brushings from human subjects demonstrated that several ATF6 alpha-related transcripts were significantly upregulated in patients with asthma compared with healthy subjects. Collectively, these results demonstrate that CBA-based therapy potently inhibits the allergen-induced UPR and allergic airway disease in mice via preferential binding of the canonical transducer of the UPR, ATF6 alpha. These results potentially suggest a novel avenue to treat allergic asthma using select CBAs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available